Status:

COMPLETED

Coagulopathy on the First Postoperative Day Predicts the Long-term Survival of Traumatic Brain Injury Patients

Lead Sponsor:

Tang-Du Hospital

Conditions:

Traumatic Brain Injury

Coagulation Disorder

Eligibility:

All Genders

18-80 years

Brief Summary

The purpose of this study was to identify the relationship between coagulopathy during the perioperative period (before the operation and on the first day after the operation) and the long-term surviv...

Detailed Description

Traumatic brain injury (TBI) is one of the leading causes of death and disability worldwide, and it represents a global health concern and financial burden \[1, 2\]. The main causes of early death in ...

Eligibility Criteria

Inclusion

  • The interval between injury and admission is less than 24 hours
  • Age\>18yrs and age\<80yrs
  • Non-head abbreviated injury score \< 3
  • Did not undertake treatment before enrollment

Exclusion

  • Take anticoagulants or antiplatelet drugs
  • Hemorrhagic or ischemic cerebrovascular disease occurred within six months
  • Other systemic diseases: uremia, cirrhosis, malignant tumor, etc

Key Trial Info

Start Date :

October 1 2019

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

January 31 2020

Estimated Enrollment :

447 Patients enrolled

Trial Details

Trial ID

NCT04322721

Start Date

October 1 2019

End Date

January 31 2020

Last Update

March 26 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Tandu Hospital, Fourth Military Medical University

Xi'an, Shaanxi, China, 710038